참고문헌
-
$EvaluatePharma^{(R)}$ . World Preview 2015, Outlook to 2020, 8th ed. Evaluate Ltd., 2015; 25. - Shenoy P. Multi-regional clinical trials and global drug development. Perspect Clin Res 2016;7:62-7. https://doi.org/10.4103/2229-3485.179430
-
MFDS, Analysis of approval status of '14 clinical trial; 607 in '
$13{\rightarrow}652$ in '14. Osong. Ministry of Food and Drug Safety, 2015. Available from http://www.mfds.go.kr/index.do?x=23&searchkey=title:cotents&mid=675&searcword=14%B3%E2%20%C0%D3%BB%F3%BD%C3%C7%E8&y=3&division=&pageNo=1&seq=26363&sitecode=1&cmd=v. Accessed September 10, 2017 - Maeda H, Kurokawa T. Recent trends for drug lag in clinical development of oncology drugs in Japan: does the oncology drug lag still exist in Japan? Int J Clin Oncol 2015;20:1072-80. https://doi.org/10.1007/s10147-015-0825-4
- Yang H. Investigation on Multi-Regional Clinical Trial (MRCT). Regulatory Research on Food, Drug & Cosmetic 2014;9:149-57.
- Japan Pharmaceuticals and Medical Devices Agency. Basic principles on global clinical trials, Notification No.0928010. Available from https://www.pmda.go.jp/files/000157900.pdf. Accessed September 10, 2017
- Tanaka A, Asano K, Uyama Y. How should ethnicity-related information be included on drug labels? Considerations based on comparison of multiregional clinical trial data on the label between Japan and the United States. Clin Pharmacol Ther 2015;98:480-2. https://doi.org/10.1002/cpt.197
- Wang SJ. Multi-regional clinical trials-what are the challenges? Pharm Stat 2010;9:171-2.st https://doi.org/10.1002/pst.457
- ICH harmonised guideline - General principles for planning and design of multi-regional clinical trials E17 (draft). International Concil for Harmonisation. Available from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E17/ICH_E17_draft_Step_1.pdf. Accessed September 10, 2017
- ICH harmonised guideline - General principles for planning and design of multi-regional clinical trials E17. International Concil for Harmonisation. Available from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E17/E17EWG_Step4_2017_1116.pdf. Accessed April 30, 2018
- MFDS, Demonstrated the level of developed countries by regulating pharmaceuticals through ICH subscription; The sixth member of the regulatory body, including the United States, Europe, and Japan, Raise international credibility and expect pharmaceutical exports to activate. Osong, Ministry of Food and Drug Safety. Available from http://www.mfds.go.kr/index.do?x=38&searchkey=title:contents&mid=675&searchword=ICH&y=7&division=&pageNo=1&seq=34354&sitecode=1&cmd=v. Acce ssed September 10, 2017
- US Food and Drug Administration. Available from https://www.fda.gov. Accessed September 10, 2017
- European Medicines Agency. Available from http://www.ema.europa.eu/ema. Accessed September 10, 2017
- Ministry of Health, Labour and Welfare. Available from http://www.mhlw.go.jp/english. Accessed September 10, 2017
- Pharmaceuticals and Medical Devices Agency. Available from https://www.pmda.go.jp/english. Accessed September 10, 2017
- China Food and Drug Administration. Available from http://eng.sfda.gov.cn/WS03/CL0755. Accessed September 10, 2017
- International Concil for Harmonisation. Available from http://www.ich.org. Accessed September 10, 2017
- US Department of Health and Human Services, Food and Drug Administration. Strategy and implementation plan for advancing regulatory science for medical products. Available from https://www.fda.gov/downloads/RegulatoryInformation/LawsEnforcedbyFDA/SignificantAmendmentstotheFDCAct/FDASIA/UCM359956.pdf. Accessed September 10, 2017
- Chakravarty AG. Multi-regional clinical trials - considerations in design and analysis. In: Global drug development and its impact on CDER's drug review process symposium, Washington DC, USA, Jun 24, 2014.
- US Food and Drug Administration, CFR - Code of Federal Regulations Title 21. Available from https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfcfr/CFRSearch.cfm?fr=314.106. Accessed September 10, 2017
- Guidance for Industry and Food and Drug Administration Staff - collection of race and ethnicity data in clinical trials. U.S. Department of Health and Human Services (HHS), Food and Drug Administration (FDA). Available from https://www.fda.gov/downloads/regulatoryinformation/guidances/ucm126396.pdf. Accessed September 10, 2017
- European Commission DIRECTIVE 2001/20/EC, The European parliament and of the council of 4 April 2001. Available from https://ec.europa.eu/health/sites/health/files/files/eudralex/vol-1/dir_2001_20/dir_2001_20_en.pdf. Accessed September 10, 2017
- Regulation (EC) No 726/2004 - Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency. European Parliament and of the Council. Available from https://ec.europa.eu/health/ sites/health/files/files/eudralex/vol-1/reg_2004_726/ reg_2004_726_en.pdf. Accessed September 10, 2017
- Reflection paper on the extrapolation of results from clinical studies conducted outside of the EU to the EU population (EMEA/CHMP/EWP/692702/2008). European Medicines Agency. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2012/04/WC500125437.pdf. Accessed September 10, 2017
- Reflection paper on ethical and GCP aspects of clinical trials of medicinal products for human use conducted outside of the EU/EEA and submitted in marketing authorisation applications to the EU Regulatory Authorities (EMA/121340/2011). European Medicines Agency. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_procedural_guideline/2012/04/WC7500125437.pdf. Accessed September 10, 2017
- Guideline on the investigation of subgroups in confirmatory clinical trials (EMA/CHMP/539146/2013). European Medicines Agency, 2014. Available from http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2014/02/WC500160523.pdf. Accessed September 10, 2017
- Jung YT. Generic drug evaluation analysis system of important export target country. Ministry of Food and Drug Safety. Available from http://www.riss.kr/search/detail/DetailView.do?p_mat_type=d7345961987b50bf&control_no=a305d09b08c8bbb8ffe0bdc3ef48d419. Accessed September 10, 2017
- Licensing Report Series -5: Japanese drug authorization system. APEC Harmonization Center. 2016.
- Basic principles on global clinical trials (reference cases). Japan Pharmaceuticals and Medical Devices Agency. Available from http://www.pmda.go.jp/files/000157520.pdf. Accessed September 10, 2017
- Basic principles for conducting phase I trials in the Japanese population prior to global clinical trials. Japan Pharmaceuticals and Medical Devices Agency. Available from http://www.pmda.go.jp/files/000157777.pdf. Accessed September 10, 2017
- Provisions for drug registration (SFDA Order No. 28). Chinese Food and Drug Administration. Available from http://eng.sfda.gov.cn/WS03/CL0768/61645.html. Accessed September 10, 2017
- Guidance for international multicenter clinical trials trial implementation. Chinese Food and Drug Administration. Available from http://www.sfda.gov.cn/WS01/CL1236/114002.html. Accessed September 10, 2017
- International Concil for Harmonisation. ICH harmonised guideline - Ethnic factors in the acceptability of foreign clinical data E5 (R1). Available from http://www.ich.org/fileadmin/Public_Web_Site/ICH_Products/Guidelines/Efficacy/E5_R1/Step4/E5_R1__Guideline.pdf. Accessed April 30, 2018
- ICH Steering Committee. Final Concept Paper E17: General principle on planning/designing Multi-Regional Clinical Trials dated 21 May 2014. Available from http://www.ich.org/products/guidelines/efficacy/article/efficacy-guidelines.html. Accessed September 10, 2017
- Ministry of Food and Drug Safety. Multiregional clinical trials' discussion. Available from http://www.nifds.go.kr/nifds/01_about/about08/about08_03d.jsp?mode=view&article_no=6175&pager.offset=0&board_no=55. Accessed April 30, 2018
- Korea National Enterprise for Clinical Trial. Available from https://www.konect.or.kr. Accessed April 30, 2018
피인용 문헌
- Perspectives on Adopting the Guideline for Multi-regional Clinical Trials in Korea: A Multi-stakeholder Survey vol.29, pp.4, 2019, https://doi.org/10.24304/kjcp.2019.29.4.267